FDA approves RxSight's light adjustable lens
Generics | News | 0 Comment | 23 Nov, 2017
Singapore – RxSight (a US based medical devices company) announced that the U.S. Food and Drug Administration (FDA) has approved the RxSight Light Adjustable Lens and the Light Delive...Read more
PeptiDream announces collaboration with Bayer
Generics | News | 0 Comment | 21 Nov, 2017
Japan based biopharma company PeptiDream Inc. has announced that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG. Under the agreement, PeptiDream wil...Read more
Ionis Pharmaceuticals licenses second antisense GI Drug to Janssen
Generics | News | 0 Comment | 17 Nov, 2017
U.S. based Pharma Company Ionis Pharmaceuticals, Inc. has announced that it has licensed a second orally delivered Generation 2.5 antisense drug to Janssen Biotech, Inc. (Janssen)...Read more
Cue Biopharma announces research collaboration with Merck
Generics | News | 0 Comment | 17 Nov, 2017
US based pharma company Cue Biopharma™, Inc. has announced a strategic strategic research collaboration and license agreement with Merck. Under the terms of the deal, the CUE Biologi...Read more
Generic Acticlate tablets launched by Lupin in USA
Generics | News | 0 Comment | 06 Nov, 2017
Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablets USP, 75 mg and 150 mg after an approval from the United States Food and Drug Administration (FDA). Lupin’s ...Read more
Lupin net profit falls 31% in Q2 to Rs 455
Generics | News | 0 Comment | 31 Oct, 2017
Pharma company Lupin reported its financial performance for the second quarter ending September 30th, 2017. The company reported net profit of Rs 662.9 in the same period of previous year....Read more
Lupin receives FDA approval for generic Axiron topical solution
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has received final approval for its Testosterone Topical Solution, 30 mg per actuation from the United States Food and Drug Administration (FDA) to market a generic versi...Read more
Lupin receives FDA approval for generic Lodosyn tablets and Kapvay Extended-Release tablets
Generics | News | 0 Comment | 27 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Carbidopa Tablets, 25 mg and Clonidine Hydrochloride Extended-Release Tablets, 0.1 mg from the United States Foo...Read more
US FDA approves Bydureon BCise by AstraZeneca for type-2 diabetes
Generics | News | 0 Comment | 23 Oct, 2017
Biopharma company AstraZeneca has announced its US Food and Drug Administration (FDA) approved Bydureon BCise (exenatide extended-release) injectable suspension. The new for...Read more
NCD: A major public health challenge for Asia-Pacific
Generics | News | 0 Comment | 11 Oct, 2017
Incidence of non-communicable diseases (NCDs) is on the rise, globally as well as in Asia Pacific region. Implications are far reaching too – while on one hand, it results in a loss o...Read more
Lupin receives FDA approval for generic Corgard Tablets
Generics | News | 0 Comment | 10 Oct, 2017
Pharma Major Lupin has announced that it has received final approval for its Nadolol Tablets USP, 20 mg, 40 mg, and 80 mg from the United States Food and Drug Administration (FDA) to market...Read more
"Biomarkers can play a key role in improving diagnosis and disease management of heart failure. "
Generics | Opinion | 0 Comment | 10 Oct, 2017
Singapore - Southeast Asia is home to 9 million heart failure patients. In Singapore alone, it accounts for around 6,000 hospitalizations. Worryingly, not only is heart failure prevalence o...Read more
Arthritis: Act before it gets Late
Generics | News | 0 Comment | 13 Sep, 2017
Started in 1996, October 12 is recognised as the World Arthritis Day (WAD). Established by Arthritis and Rheumatism International (ARI) and supported by the European League Against Rheumati...Read more
Michigan third most preferred destination in Midwest for life science investment
Generics | News | 0 Comment | 11 Sep, 2017
Michigan ranked third among 11 Midwest regions for the value of equity investments made in life sciences companies during the first half of 2017. A midyear report from Cleveland-base...Read more
Eli Lilly to invest more in new medicines and drive growth
Generics | News | 0 Comment | 08 Sep, 2017
Eli Lilly and Company has decided to streamline operations to more efficiently focus resources on developing new medicines and to improve its cost structure. Global workforce reductions, in...Read more
Lupin launches generic Benicar tablets in the US
Generics | News | 0 Comment | 04 Sep, 2017
Pharma company Lupin Limited has announced the launch of its Olmesartan Medoxomil tablets, 5 mg, 20 mg and 40 mg having received an approval from the United States Food and Drug Administrat...Read more
U.S. FDA approves chemo group's benznidazole to treat children with Chagas disease
Generics | News | 0 Comment | 01 Sep, 2017
Singapore – The U.S. Food and Drug Administration (FDA) approved Chemo Research's New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat...Read more
Battlefield Acupuncture (BFA): New pain management process for the military
Generics | News | 0 Comment | 27 Aug, 2017
Singapore - With the pressing need for more efficient and agile pain management practices for military service personnel, Dr. Richard C. Neimtzow of Andrews Air force base d...Read more